Gastroenterology Archives - Page 3 of 4

Hospital resource use and cost associated with first-line anti-TNF therapy in patients with inflammatory bowel disease in the UK: comparison of subcutaneous (adalimumab) and intravenous (infliximab) therapies

Authors: J Hickey, S Keshav, S Gaugris, R Arasaradnam Published: Journal of Crohn's and Colitis, 2017 View publication Background UK National Institute for Health and Care Excellence guidance states that if more...

Real world use of adalimumab: effects on corticosteroid treatment and hospital resource utilisation in UK patients with moderate/severe ulcerative colitis

Authors: G Watts, R Arasaradnam, A Sharma, A Awasthi, J Limdi, A Bishop-Bailey, S Mclain-Smith, T Finney-Hayward Published: Journal of Crohn's and Colitis, 2017 View publication Background Anti-TNF therapies are used to...

Structured transition enhances clinical outcome without an increase in healthcare cost in adolescent patients with IBD: The UK TRANSIT Study

Authors: S McCartney, J O Lindsay, R K Russell, D R Gaya, I Shaw, C Murray, T Finney-Hayward, S Sebastian Published: Journal of Crohn's and Colitis, 2017 View publication Background IBD presents...

Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review

Authors: M C Dubinsky, I Dotan, D T Rubin, M Bernauer, D Patel, R Cheung, I Modesto, M Latymer, L Keefer Published: Expert Review of Gastroenterology & Hepatology, 2021 View publication Introduction...

Projected impact of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 and chronic kidney disease in Vietnam

Authors: C Nwankwo, S L Corman, E H Elbasha Published: Journal of Infection and Public Health, 2019 View publication Background Hepatitis C virus (HCV) infection is an important cause of morbidity and...

The latest in IBD from the European Crohn’s and Colitis Organisation (ECCO) 2019 Congress

The 14th ECCO Congress was held in Copenhagen, Denmark this year, and welcomed over 6,500 participants to share the most recent updates in inflammatory bowel disease (IBD). Under the theme of ‘research...

Qualitative development of a patient-reported outcome symptom measure in diarrhea-predominant irritable bowel syndrome

Authors: P Marquis, K E Lasch, L Delgado-Herrera, S Kothari, A Lembo, C Lademacher, G Spears, A Nishida, W L Tesler, E Piault, K Rosa, B Zeiher. Published: Clinical and Translational Gastroenerology,...

Cultural adaptation: translatability assessment and linguistic validation of the patient-reported outcome instrument for irritable bowel syndrome with diarrhea

Authors: L Delgado-Herrera, K Lasch, A Popielnicki, A Nishida, R Arbuckle, B Banderas, S Zentner, I Gagainis, B Zeiher Published: Patient Related Outcome Measures, 2016 View publication Objectives Following a 2009 US...

Systematic review: treatment pattern and clinical effectiveness and safety of pharmaceutical therapies for Crohn’s disease in Europe

Authors: F Lelli, S Nuhoho, X Y Lee, W Xu Published: Clinical and experimental gastroenterology, 2016 View publication Background Although many clinical trials have been conducted in treatments of Crohn’s disease (CD),...

News